Cargando…

Prerequisites for a dry powder inhaler for children with cystic fibrosis

Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient’s inhalation manoeuvre. Children are an especially challenging target population for DPI development due to the large variability in understanding and insp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lexmond, Anne J., Hagedoorn, Paul, Frijlink, Henderik W., Rottier, Bart L., de Boer, Anne H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553717/
https://www.ncbi.nlm.nih.gov/pubmed/28800360
http://dx.doi.org/10.1371/journal.pone.0183130
_version_ 1783256660445233152
author Lexmond, Anne J.
Hagedoorn, Paul
Frijlink, Henderik W.
Rottier, Bart L.
de Boer, Anne H.
author_facet Lexmond, Anne J.
Hagedoorn, Paul
Frijlink, Henderik W.
Rottier, Bart L.
de Boer, Anne H.
author_sort Lexmond, Anne J.
collection PubMed
description Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient’s inhalation manoeuvre. Children are an especially challenging target population for DPI development due to the large variability in understanding and inspiratory capacities. We previously performed a study in which we determined the prerequisites for a paediatric DPI in a mostly healthy paediatric population, for which we used an empty test inhaler with variable internal airflow resistance and mouthpiece. In the current study we investigated what specifications are required for a DPI for children with cystic fibrosis (CF), for which we expanded on our previous findings. We recorded flow profiles of 35 children with CF (aged 4.7–14.7 years) at three airflow resistances (0.031–0.045 kPa(0.5).min.L(-1)) from which various inspiratory parameters were computed. Obstructions in the mouth during inhalation were recorded with a sinuscope. All children were able to perform a correct inhalation manoeuvre, although video analysis showed that children did not place the inhaler correctly in the mouth in 17% of the cases. No effect was found of medium to high airflow resistance on total inhaled volume, which implies that the whole resistance range tested is suitable for children with CF aged 4–14 years. No effect could be established of either mouthpiece design or airflow resistance on the occurrence of obstructions in the mouth cavity. This study confirms our previous conclusion that the development of DPIs specifically for children is highly desired. Such a paediatric DPI should function well at 0.5 L inhaled volume and a peak inspiratory flow rate of 20 to 30 L/min, depending on the internal airflow resistance. This resistance can be increased up to 0.045 kPa(0.5).min.L(-1) (medium-high) to reduce oropharyngeal deposition. A higher resistance may be less favourable due to its compromising effect on PIF and thereby on the energy available for powder dispersion.
format Online
Article
Text
id pubmed-5553717
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55537172017-08-25 Prerequisites for a dry powder inhaler for children with cystic fibrosis Lexmond, Anne J. Hagedoorn, Paul Frijlink, Henderik W. Rottier, Bart L. de Boer, Anne H. PLoS One Research Article Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient’s inhalation manoeuvre. Children are an especially challenging target population for DPI development due to the large variability in understanding and inspiratory capacities. We previously performed a study in which we determined the prerequisites for a paediatric DPI in a mostly healthy paediatric population, for which we used an empty test inhaler with variable internal airflow resistance and mouthpiece. In the current study we investigated what specifications are required for a DPI for children with cystic fibrosis (CF), for which we expanded on our previous findings. We recorded flow profiles of 35 children with CF (aged 4.7–14.7 years) at three airflow resistances (0.031–0.045 kPa(0.5).min.L(-1)) from which various inspiratory parameters were computed. Obstructions in the mouth during inhalation were recorded with a sinuscope. All children were able to perform a correct inhalation manoeuvre, although video analysis showed that children did not place the inhaler correctly in the mouth in 17% of the cases. No effect was found of medium to high airflow resistance on total inhaled volume, which implies that the whole resistance range tested is suitable for children with CF aged 4–14 years. No effect could be established of either mouthpiece design or airflow resistance on the occurrence of obstructions in the mouth cavity. This study confirms our previous conclusion that the development of DPIs specifically for children is highly desired. Such a paediatric DPI should function well at 0.5 L inhaled volume and a peak inspiratory flow rate of 20 to 30 L/min, depending on the internal airflow resistance. This resistance can be increased up to 0.045 kPa(0.5).min.L(-1) (medium-high) to reduce oropharyngeal deposition. A higher resistance may be less favourable due to its compromising effect on PIF and thereby on the energy available for powder dispersion. Public Library of Science 2017-08-11 /pmc/articles/PMC5553717/ /pubmed/28800360 http://dx.doi.org/10.1371/journal.pone.0183130 Text en © 2017 Lexmond et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lexmond, Anne J.
Hagedoorn, Paul
Frijlink, Henderik W.
Rottier, Bart L.
de Boer, Anne H.
Prerequisites for a dry powder inhaler for children with cystic fibrosis
title Prerequisites for a dry powder inhaler for children with cystic fibrosis
title_full Prerequisites for a dry powder inhaler for children with cystic fibrosis
title_fullStr Prerequisites for a dry powder inhaler for children with cystic fibrosis
title_full_unstemmed Prerequisites for a dry powder inhaler for children with cystic fibrosis
title_short Prerequisites for a dry powder inhaler for children with cystic fibrosis
title_sort prerequisites for a dry powder inhaler for children with cystic fibrosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553717/
https://www.ncbi.nlm.nih.gov/pubmed/28800360
http://dx.doi.org/10.1371/journal.pone.0183130
work_keys_str_mv AT lexmondannej prerequisitesforadrypowderinhalerforchildrenwithcysticfibrosis
AT hagedoornpaul prerequisitesforadrypowderinhalerforchildrenwithcysticfibrosis
AT frijlinkhenderikw prerequisitesforadrypowderinhalerforchildrenwithcysticfibrosis
AT rottierbartl prerequisitesforadrypowderinhalerforchildrenwithcysticfibrosis
AT deboeranneh prerequisitesforadrypowderinhalerforchildrenwithcysticfibrosis